PB 83 of 2025
National Health (August 2025 First New Brand statutory price reduction) (Exercise of Ministerial discretion) Determination 2025
I, Rebecca Richardson, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make the following determination.
Dated 26 June 2025
REBECCA RICHARDSON
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health, Disability and Ageing
1 Name
(1) This instrument is the National Health (August 2025 First New Brand statutory price reduction) (Exercise of Ministerial discretion) Determination 2025.
(2) This instrument may also be cited as PB 83 of 2025.
2 Commencement
This instrument commences on 1 August 2025.
3 Authority
This instrument is made under subsection 99ACD(7A) of the National Health Act 1953.
4 Definitions
Note: A number of expressions used in this instrument are defined in Part VII the Act.
In this instrument:
Act means the National Health Act 1953.
5 Brand of pharmaceutical item not subject to a price reduction
- I determine under paragraph 99ACD(7A)(a) of the Act that the agreed price of the brand of pharmaceutical item specified in item 1 in the table in Part 1 of Schedule 1 that comes into force on 1 August 2025 is to be equal to the approved ex‑manufacturer price, on the day before the determination day, of the existing brand of the existing item.
Schedule 1 Brands of pharmaceutical item not subject to a price reduction
Part 1
Column 1 | Column 2 | |||
Item | Brand of pharmaceutical item | |||
| Drug | Form | Manner of administration | Brand |
1 | Drospirenone with ethinylestradiol | Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol and 4 inert tablets | Oral | Bella |
2 | Drospirenone with ethinylestradiol | Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol and 4 inert tablets | Oral | Rosie |
3 | Drospirenone with ethinylestradiol | Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol and 4 inert tablets | Oral | YANA |
4 | Drospirenone with ethinylestradiol | Pack containing 21 tablets 3 mg drospirenone with 30 micrograms ethinylestradiol and 7 inert tablets | Oral | Isabelle |
5 | Drospirenone with ethinylestradiol | Pack containing 21 tablets 3 mg drospirenone with 30 micrograms ethinylestradiol and 7 inert tablets | Oral | Rosalee |
6 | Drospirenone with ethinylestradiol | Pack containing 21 tablets 3 mg drospirenone with 30 micrograms ethinylestradiol and 7 inert tablets | Oral | Yelena
|